Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_assertion description "[Compared with the drug-resistance group, the Ca2+ concentration in cells and the expression of LRP in lung cancer drug-resistance cells A549/DDP of the high-dose group, the low-dose group and the normal group of Chinese medicine were significantly different (all P<0.01), the LRP expression of the normal group was obviously higher than that of the drug-resistance group (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_assertion evidence source_evidence_literature NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_assertion SIO_000772 18219453 NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_assertion wasDerivedFrom befree-20140225 NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_assertion wasGeneratedBy ECO_0000203 NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP926285.RAGoY4_TK2h5mj8nz_nEE7X_7f0gOXntYTuk849a5TMc0130_provenance.